Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Comparative Effectiveness Research|January 18, 2020
Experimental design issues in choice-based conjoint applied to patient choice in healthcarePallavi Chitturi, Alexandra CaridesFuture Oncology (London, England)|August 31, 2013
Analysis of aprepitant for prevention of chemotherapy-induced nausea and vomiting with moderately and highly emetogenic chemotherapyAlex Molassiotis, Allison Martin Nguyen, Cynthia N Rittenberg, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 27, 2002
A study evaluating the efficacy, safety, and tolerability of ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adultsGuillermo Ortiz-Ruiz, Jose Caballero-Lopez, Ian R Friedland, et al.The Journal of Antimicrobial Chemotherapy|May 20, 2004
Ertapenem versus ceftriaxone for the treatment of community-acquired pneumonia in adults: combined analysis of two multicentre randomized, double-blind studiesGuillermo Ortiz-Ruiz, Norbert Vetter, Robin Isaacs, et al.The Oncologist|March 22, 2015
Aprepitant and fosaprepitant: a 10-year review of efficacy and safetyMatti Aapro, Alexandra Carides, Bernardo L Rapoport, et al.Clinical Therapeutics|December 28, 2002
A prospective, randomized, double-blind multicenter comparison of parenteral ertapenem and ceftriaxone for the treatment of hospitalized adults with community-acquired pneumoniaNorbert Vetter, Eduardo Cambronero-Hernandez, Jane Rohlf, et al.Journal of Neurovirology|May 13, 2014
Changes in PINCH levels in the CSF of HIV+ individuals correlate with hpTau and CD4 countRadhika Adiga, Ahmet Y Ozdemir, Alexandra Carides, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 2, 2009
Aprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with a broad range of moderately emetogenic chemotherapies and tumor types: a randomized, double-blind studyBernardo L Rapoport, Karin Jordan, Judith A Boice, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 9, 2011
Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with cisplatin therapy: randomized, double-blind study protocol--EASESteven Grunberg, Daniel Chua, Anish Maru, et al.Journal of Clinical Pharmacology|February 20, 2004
Indinavir and rifabutin drug interactions in healthy volunteersWalter K Kraft, Jacqueline B McCrea, Gregory A Winchell, et al.Pageof 2